Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder

Summary

The purpose of this study is to allow patients with specific needs for inhaled insulin to continue with inhaled insulin therapy using Technosphere Insulin after Exubera was withdrawn from the market.

Timeline

Start

2008-10

Primary completion

2015-04

Completion

2015-05

Drugs

Indications